Tumor-Agnostic Indications: Which Direction are We Going?

The future belongs to technologies. It is certainly true in medicine, but particularly in clinical oncology. Immense improvements and advancements in many fields of medicine have already resulted in overall prolongation of life and improvement in its quality. However, there are still many aggressive, rapidly progressing malignant diseases that are associated with a short median survival time, despite all advances and development of high-resolution technologies, new drugs, and various treatment policies. In this work, we want to present, describe, and discuss the most promising, molecular advances in cancer research in our opinion that we believe would soon change the face of modern oncology.